Howard Colman, MD, PhD | Authors

SCOLARIS FOOD & DRUG CO

PO BOX 51522

Sparks

89435

Articles

Medulloblastoma: Molecular Classifications and Prognostic Associations

November 15, 2012

Of particular relevance for clinicians is the possible recommendation of omitting concurrent chemotherapy with CSI in adults, due to the lower marrow reserves and overall lack of data for clear efficacy of concurrent chemotherapy in adults. Additional refinement of these therapeutic regimens for adult medulloblastoma awaits further advances in both the molecular prognostic associations for these tumors and the potentially exciting development of targeted therapies for specific molecular subtypes.